Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 study evaluating safety, tolerability and preliminary efficacy of sublingual liraglutide in adults with type 2 diabetes mellitus; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Biolingus | Conditions: Diabete Type 2 | Phase 1, Phase 2 | Status: RECRUITING